METI MEDI
Live / Registered — Registered (as of 16 Jun 2020)
What this means for you
Registered since 16 Jun 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88189793
- Registration number
- 6077567
- Mark type
- Design + words
- Filed
- 12 Nov 2018
- Published for opposition
- 31 Mar 2020
- Registered
- 16 Jun 2020
- Attorney of record
- N. Christopher Norton
Goods and services
- Class 005 — Pharmaceuticals: Anti-cancer preparations; Pharmaceutical agents affecting metabolism; Pharmaceutical preparations for immunity adjustment; Vaccines; Pharmaceutical agents for regenerating cells; Anti-inflammatory preparations; Pharmaceutical agents affecting digestive organs; Cardiovascular pharmaceutical preparations; Chemical preparations for pharmaceutical purposes, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemico-pharmaceutical preparations, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Pharmaceuticals for medical purposes for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Antibacterial substances for medical purposes; Antibodies for medical purposes for the treatment of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Chemical preparations for medical purpose, namely, for the diagnosis, monitoring, treatment and prevention of immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic kits for medical diagnostic purposes comprising reagents for use in disease testing, health monitoring and more generally, predictive and preventive medicine in the fields of detecting immune system related diseases, cancer, infectious diseases, inflammatory disorders and oncological disorders; Diagnostic pharmaceutical preparations for medical purposes; Antibiotics; Tumor suppressing agents; Chemotherapeutics
Owner
- MetiMedi Pharmaceuticals Co., Ltd., Incheon, KR
- MetiMedi Pharmaceuticals Co., Ltd., Incheon, KR
- MetiMedi Pharmaceuticals Co., Ltd., Incheon, KR
Prosecution history
- 16 Jun 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 17 Mar 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Mar 2022 — TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
- 17 Mar 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 17 Mar 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Mar 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 31 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 Mar 2020 — PUBLISHED FOR OPPOSITION
- 11 Mar 2020 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Jan 2020 — CASE RETURNED TO EXAMINATION
- 27 Jan 2020 — NOTICE OF ALLOWANCE CANCELLED
- 27 Jan 2020 — PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
- 16 Jan 2020 — TEAS RESPONSE TO PETITION INQUIRY LETTER
- 10 Jan 2020 — PETITION INQUIRY LETTER ISSUED